Deubiquitinase CYLD acts as a negative regulator of dopamine neuron survival in Parkinson’s disease
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
Research suggests that the deubiquitinase CYLD plays a role in the survival of dopamine neurons in Parkinson's disease. CYLD is reported to act as a negative regulator of dopamine neuron survival. This finding may be relevant to understanding the disease.